(Q33346685)

English

Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

0 references

Ebenezer Daniel

object named as

Ebenezer Daniel

3

0 references

Grace A Levy-Clarke

4

object named as

Grace A Levy-Clarke

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Robert B. Nussenblatt

5

object named as

Robert B Nussenblatt

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Kathy J. Helzlsouer

11

object named as

Kathy J Helzlsouer

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

7

object named as

Eric B Suhler

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jennifer Thorne

8

object named as

Jennifer E Thorne

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

10

object named as

Douglas A Jabs

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1

object named as

John H Kempen

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Sapna Gangaputra

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

James T Rosenbaum

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

C Stephen Foster

9

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

0 references

publication date

25 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

American Journal of Ophthalmology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

146

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

802-12.e1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Epstein-Barr virus: evasive maneuvers in the development of PTLD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Solid malignancies among patients in the Wegener's Granulomatosis Etanercept Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Safety of extended treatment with anakinra in patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Safety of mycophenolate mofetil versus azathioprine in renal transplantation: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Malignancy in organ transplantation: heart

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Inhibitors of mammalian target of rapamycin as novel antitumor agents: from bench to clinic.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

One thousand renal transplants at Belfast City Hospital: post-graft neoplasia 1968-1999, comparing azathioprine only with cyclosporin-based regimes in a single centre

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Diagnosis and management of posttransplant lymphoproliferative disorder in solid-organ transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Incidence of skin cancer in 5356 patients following organ transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Activation of p70 ribosomal protein S6 kinase is an essential step in the DNA damage-dependent signaling pathway responsible for the ultraviolet B-mediated increase in interstitial collagenase (MMP-1) and stromelysin-1 (MMP-3) protein levels in huma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Atherosclerosis — An Inflammatory Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

p53 mutations implicate sunlight in post-transplant skin cancer irrespective of human papillomavirus status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

The effect of immunosuppression on pre-existing cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Effects of cyclophosphamide on the development of malignancy and on long‐term survival of patients with rheumatoid arthritis a 20‐year followup study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Incidence of second cancers in patients treated for Hodgkin's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Survival and drug discontinuation analyses in a large cohort of methotrexate treated rheumatoid arthritis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

The comparative incidence of malignant disease in rheumatoid arthritics exposed to different treatment regimens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Review of United States data on neoplasms in rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Carcinoma of the Urinary Bladder after Treatment with Cyclophosphamide for Non-Hodgkin's Lymphoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Toxic effects of azathioprine in rheumatoid arthritis. A national post-marketing perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Incidence of skin cancer after renal transplantation in The Netherlands.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Cyclosporin abrogates virus-specific T-cell control of EBV-induced B-cell lymphoproliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Is methotrexate therapy for psoriasis carcinogenic? A modified retrospective-prospective analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

The Incidence Of Bladder Cancer after Cyclophosphamide Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Acute myelogenous leukemia in patients receiving chlorambucil as long-term adjuvant chemotherapy for stage II breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

Cyclophosphamide and malignancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

21 June 2018

The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Mycophenolate mofetil and risk of developing malignancy after orthotopic heart transplantation: analysis of the transplant registry of the International Society for Heart and Lung Transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Individualization of immunosuppressive therapy. III. Sirolimus associated with a reduced incidence of malignancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

The immunosuppressive drug mycophenolate mofetil impairs the adhesion capacity of gastrointestinal tumour cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Is posttransplant lymphoproliferative disorder (PTLD) caused by any specific immunosuppressive drug or by the transplantation per se?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Risk factors associated with the development of skin cancer after liver transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Risk factors for posttransplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Cyclosporine induces cancer progression by a cell-autonomous mechanism.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Wegener Granulomatosis: An Analysis of 158 Patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2614443

31 October 2018

Second neoplasm--a complication of cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequency of malignant neoplasms in 248 long-term methotrexate-treated psoriatics. A preliminary study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mutagenicity of cyclosporine. Induction of sister chromatid exchange in human cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genotoxic potential of cyclosporin A in patients with renal transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leukemia after therapy with alkylating agents for childhood cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Malignancy following treatment of rheumatoid arthritis with cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The oncogenicity of chlorambucil in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Absence of genotoxic potential for cyclosporine in experimental systems

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Skin lesions in renal transplant patients after 10-23 years of immunosuppressive therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term experience with low dose methotrexate in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The incidence of cancer associated with the treatment of rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymphomas after solid organ transplantation: a collaborative transplant study report

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aggressive treatment for postcardiac transplant lymphoproliferation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic immunosuppressive therapy and the occurrence of malignancy in patients with ocular inflammatory disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-lymphoid cancer after liver transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

INTERLEUKIN-10 AND POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER AFTER KIDNEY TRANSPLANTATION1

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prednisone and prednisolone in ocular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No evidence for increased risk of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis receiving etanercept for up to 5 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/18579112

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.AJO.2008.04.035

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33346685&oldid=2013954686"